$11.66

0.09 (0.77%)

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

FPH General Information

Fisher & Paykel Healthcare Corporation Limited
FPH
http://www.fphcare.com
Health Care Equipment
6,735
573

FPH Current Share Price+

Current Price $11.660
Open $11.740
High $12.190
Low $11.625
Last Close $11.750
Volume 455950
Price Movement $0.09 ( 0.77% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

FPH Research

FPH Recommendation

Current recommendation UNLOCK
12 month range UNLOCK
Maximum portfolio weighting UNLOCK
Business risk UNLOCK
Share price risk UNLOCK

FPH Company Overview

Business Description

Fisher & Paykel Healthcare Corporation Limited (FPH) is a New Zealand-based company engaged in design, development, manufacture and marketing of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. FPH currently sells its products and systems in over 120 countries worldwide.

FPH Financial Summary

Year to Mar NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 F 219.35 38.43 14.90% 30.58 26.91 2.29% 100.0%
2019 F 190.86 33.44 8.20% 35.14 23.36 1.99% 100.0%
2018 A 176.11 30.90 10.60% 36.20 19.68 1.76% 100.0%

FPH Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2018 A 2019 F 2020 F 2018 A 2019 F 2020 F 2018 A 2019 F 2020 F
Cochlear (COH) $9,842M 0.0828 0.1186 0.1376 40.4752 36.1829 31.8064 1.76% 1.91% 2.18%
Fisher & Paykel Hlth (FPH) $6,494M 0.1095 0.0373 0.1423 33.7806 32.5668 28.5103 1.76% 2.15% 2.48%
ResMed (RMD) $22,600M 0.2815 0.1294 0.1225 36.1440 32.0016 28.5098 1.21% 1.61% 1.79%

FPH Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 1.42 34.10 9.38 3.83
Market 0.90 15.80 1.43 1.57
Sector 0.90 15.80 1.68 2.43

FPH Directors

Name Position Start Date
Mr Lewis George Gradon Chief Executive Officer, Managing Director 1 Apr 2016
Mr Antony (Tony) John Carter Non-Executive Chairman 1 Dec 2010
Mr W Lindsay Gillanders Non-Executive Director 1 May 1992
Mr Michael Grenfell Daniell Non-Executive Director 16 Nov 2001
Mr Neville Mitchell Non-Executive Director 12 Nov 2018
Mr Donal Paul O'Dwyer Non-Executive Director 1 Dec 2012
Ms Geraldine Celia McBride Non-Executive Director 1 Aug 2013
Dr Arthur James Morris Non-Executive Director 20 Feb 2008
Mr Scott Andrew St John Non-Executive Director 1 Oct 2015
Ms Philippa Mary Greenwood Non-Executive Director 1 Jun 2017

FPH Management

Name Position
Tony Barclay Chief Finance Officer,Company Secretary
Ed Timmins Company Secretary,General Counsel
Jonathan Rhodes General Manager - Supply Chain, Facilities and Environment
Paul Shearer Senior Vice President - Sales & Marketing
Debra Lumsden Vice President - Human Resources
Nicholas Fourie Vice President - Information & Communication Technology
Andrew Somervell Vice President - Products & Technology
Brian Schultz Vice President - Quality & Regulatory Affairs
Winston Fong Vice President - Surgical Technologies

FPH Calendar of Events

Date Event
25 November 2019 Report (Interim)
27 May 2019 Report (Annual)
27 May 2019 Report (Prelim)
21 December 2018 Div Pay Date

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.